The abstract is read at the publisher; the summary is JClub's.
T cells from treatment-resistant hypertension patients increase AngII-driven systolic blood pressure in humanized NSG-(KbDb)^null mice, with endothelial dysfunction linked to TNF.
- Why it matters: Adaptive immunity has been implicated in hypertension, but human evidence for a direct causal role of T cells has been lacking due to multifactorial disease mechanisms.
- What they did: PBMCs from TRH patients or healthy controls were adoptively transferred into NSG-(KbDb)^null mice, then hypertension was induced by angiotensin II infusion for 14 days with radiotelemetry monitoring.
- The result: TRH-PBMC recipients showed higher systolic blood pressure after AngII, more kidney endothelial dysfunction, elevated effector memory CD4+ and Th17 frequencies, and increased renal human T cell-derived TNF; TNF inhibition attenuated AngII-induced hypertension.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.